Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Abnormality”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)UnknownNCT01936064
What this trial is testing

The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients

Who this might be right for
Haematological Abnormality
Lagos State University 60
Not applicableStudy completedNCT03828942
What this trial is testing

Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)

Who this might be right for
Hematological AbnormalityHematotoxicity
Groupe Hospitalier Pitie-Salpetriere 1,000
Not applicableStudy completedNCT03137745
What this trial is testing

Coagulation Profile of Patients Undergoing CRS(Cytoreductive Surgery) and Hyperthermic Intraperitoneal Chemotherapy

Who this might be right for
Haematological Abnormality
Rajiv Gandhi Cancer Institute & Research Center, India 60
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70